Intersection4 Podcast - Episode #11 - Diving Deep into DeepTech

Summary In this episode, Elliot Roth, Head of Business Development in Agriculture at Deep Science Ventures, shares his journey with Spira, a bio manufacturing company. He discusses the challenges he faced, including team dynamics and resource constraints. Hamiz Awan, an investor, provides insights on the role of investors in founder conflicts. They also discuss the funding landscape for biotech startups and the potential of crypto in the industry. They explore exciting developments in biotech, such as longevity technologies and DNA data storage. The conversation concludes with a discussion on the future of biotech and the wave of speculation in the field. Takeaways Team dynamics and resource constraints are crucial factors in the success of startups. Investors play a role in mediating founder conflicts and ensuring the best interests of the company. The funding landscape for biotech startups is challenging, with longer time horizons and specialized knowledge required. The potential of crypto in biotech lies in data storage and access controls. Exciting developments in biotech include longevity technologies, cognitive systems, and bio manufacturing. The future of biotech holds opportunities for creative scientific work and the intersection of computation and biology. A wave of speculation is expected in the biotech industry. Chapters 00:00 - Introduction and Background 00:58 - Elliot's Journey with Spira 05:03 - The Importance of Team in Startups 06:15 -The Role of Investors in Founder Conflicts 10:23 - Key Traits of Successful Startups 16:14 - Challenges in Funding Biotech Startups 20:33 - The Future of Biotech Funding 23:09 - The Potential of Crypto in Biotech 29:14 - Exciting Developments in Biotech 35:30 - The Future of Biotechnology and Deep Science 38:48 - The Intersection of Computation and Biology 40:44 - Building New Businesses in Biotech 42:15 - The Wave of Speculation in Biotech 42:59 - Wrap-up and Closing